CESAR
MORIS DE LA TASSA
Catedrático de Universidad
Hospital Universitario La Fe
Valencia, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario La Fe (5)
2022
-
Rationale and design of the Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) randomized trial
European Journal of Heart Failure, Vol. 24, Núm. 3, pp. 581-588
2020
-
Transcatheter mitral repair according to the cause of mitral regurgitation: real-life data from the Spanish MitraClip registry
Revista Espanola de Cardiologia, Vol. 73, Núm. 8, pp. 643-651
-
Transcatheter mitral repair for functional mitral regurgitation according to left ventricular function: A real-life propensity-score matched study
Journal of Clinical Medicine, Vol. 9, Núm. 6, pp. 1-14
2016
-
Comparison of 1-Year Outcome in Patients with Severe Aorta Stenosis Treated Conservatively or by Aortic Valve Replacement or by Percutaneous Transcatheter Aortic Valve Implantation (Data from a Multicenter Spanish Registry)
American Journal of Cardiology, Vol. 118, Núm. 2, pp. 244-250
2013
-
In-hospital and mid-term predictors of mortality after transcatheter aortic valve implantation: Data from the Tavi national registry 2010-2011
Revista Espanola de Cardiologia, Vol. 66, Núm. 12, pp. 949-958